Skip to content
Home

Acute radiation syndrome (radiation sickness)

Acute radiation syndrome is an illness caused by short-term, high-dose exposure to ionizing radiation that damages rapidly dividing tissues; severity and outcome depend on dose and prompt medical care.

Overview

Acute radiation syndrome (ARS), often called radiation sickness or radiation poisoning, describes a set of health effects that occur after a short, high dose of ionizing radiation. Unlike long-term risks such as cancer, ARS refers to the immediate, dose-dependent damage that develops over hours to months. For general background on terms and definitions see this overview and for basic physics consult descriptions of ionizing radiation.

Image gallery

10 Images

Clinical features and typical stages

The clinical course of ARS typically follows a pattern of stages, although not every patient experiences all phases. Commonly cited stages include:

  • Prodromal phase: early nonspecific symptoms such as nausea, vomiting, fatigue and loss of appetite that can begin within minutes to days after exposure.
  • Latent phase: a deceptive improvement or quiet period when symptoms may diminish despite underlying injury.
  • Manifest illness: targeted organ systems show clear dysfunction. The most vulnerable tissues are the blood-forming (hematopoietic) system, the blood and bone marrow, the gastrointestinal tract, and at very high exposures the central nervous system and cardiovascular system.
  • Recovery or death: outcome depends on dose, supportive care, and complications such as infection and bleeding.

Causes and mechanisms

ARS results when ionizing radiation deposits enough energy in tissues to kill or impair large numbers of dividing cells. Common causes include major nuclear accidents, detonation of nuclear weapons, industrial or medical radiation accidents, and deliberate overexposure. Damage affects rapidly renewing cell populations first, producing characteristic patterns of illness.

Diagnosis and management

Diagnosis is clinical and supported by findings such as a rapid drop in lymphocyte count and measured or estimated radiation dose. Management is largely supportive: fluid and electrolyte replacement, control of infection, blood transfusions, and symptomatic care. Specific measures may include colony-stimulating factors to boost bone marrow recovery, antibiotics, and in selected cases hematopoietic stem cell transplantation. Prognosis improves with early recognition, specialized care, and resources to manage complications.

Prevention, public health and history

Prevention relies on the three basic principles of radiological protection: minimizing time near sources, maximizing distance, and using appropriate shielding and protective equipment. Public health planning for radiological incidents emphasizes rapid triage, dose estimation, and coordinated medical response. Historical events such as nuclear reactor accidents and wartime detonations have shaped modern emergency protocols and clinical knowledge about ARS.

Distinctions and notable facts

ARS should be distinguished from chronic or late effects of radiation exposure (for example, increased cancer risk), which follow different biological processes and timelines. Not everyone exposed to radiation will develop ARS; the syndrome requires sufficiently high, concentrated doses. Research and clinical experience continue to refine treatment approaches, but basic supportive care and infection control remain central to improving outcomes.

Related articles

Author

AlegsaOnline.com Acute radiation syndrome (radiation sickness)

URL: https://en.alegsaonline.com/art/823

Share

Sources